- Home
- SNY vs ISRG Comparison
SNY vs ISRG Comparison
Compare SNY & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- ISRG
- Stock Information
- Founded
- SNY 1994
- ISRG 1995
- Country
- SNY France
- ISRG United States
- Employees
- SNY N/A
- ISRG N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- ISRG Medical/Dental Instruments
- Sector
- SNY Health Care
- ISRG Health Care
- Exchange
- SNY Nasdaq
- ISRG Nasdaq
- Market Cap
- SNY 140.6B
- ISRG 170.3B
- IPO Year
- SNY N/A
- ISRG 2000
- Fundamental
- Price
- SNY $57.73
- ISRG $471.82
- Analyst Decision
- SNY Buy
- ISRG Buy
- Analyst Count
- SNY 2
- ISRG 21
- Target Price
- SNY $57.50
- ISRG $445.33
- AVG Volume (30 Days)
- SNY 1.6M
- ISRG 1.1M
- Earning Date
- SNY 10-25-2024
- ISRG 10-17-2024
- Dividend Yield
- SNY 3.53%
- ISRG N/A
- EPS Growth
- SNY N/A
- ISRG 45.89
- EPS
- SNY 3.60
- ISRG 5.82
- Revenue
- SNY $50,444,658,733.00
- ISRG $7,572,500,000.00
- Revenue This Year
- SNY $3.58
- ISRG $15.85
- Revenue Next Year
- SNY $6.99
- ISRG $15.91
- P/E Ratio
- SNY $32.20
- ISRG $81.08
- Revenue Growth
- SNY 2.25
- ISRG 13.62
- 52 Week Low
- SNY $42.63
- ISRG $254.85
- 52 Week High
- SNY $58.97
- ISRG $493.97
- Technical
- Relative Strength Index (RSI)
- SNY 71.75
- ISRG 49.72
- Support Level
- SNY $55.80
- ISRG $476.88
- Resistance Level
- SNY $58.97
- ISRG $493.44
- Average True Range (ATR)
- SNY 0.58
- ISRG 8.95
- MACD
- SNY 0.16
- ISRG -2.46
- Stochastic Oscillator
- SNY 74.38
- ISRG 20.64
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.